2Ridker PM.High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J].Circulation,2001,10(3):1813-1818.
3Haverkate F,Thompson SG,Pyker SDM,et al.Production of C-reactive protein and risk of coronary events in stable and unstable angina[J].Lancet,1997,349(9050):462-466.
1[12]Yazdani S, Simon AD, Vidhun R, Gulotta C, Schwartz A, Rabbani LE. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am Heart J, 1998, 136 (2): 357-361
2[1]Jialal I, Devaraj S. Iflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol, 2001, 116 (Suppl): S108-S115
3[2]Ridker PM, Hennekens CH, Buring JE, Raifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000, 342 (22): 836-843
4[3]Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000, 101 (15): 1 767-772
5[4]Harris TB, Ferrucci L, Tracy RP, Corti MT, Wacholder S, Ettingeret WH, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med, 1999, 106 (5): 506-512
6[6]Fazio S, Linton MF. The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall. Am J Cardiol, 2001, 88 (Suppl): 12E-15E
7[7]Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol, 2001, 88: 10K-15K
8[8]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105 (9): 1 135-142
10[10]Ridker PM, Rifai N, Pfeffer MA,Sacks F, Brauwald E. Long-term effects of pravastatin on plasma concentration of c-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation, 1999, 100 (3): 230-235
3Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the se- verity of acute coronary syndromes [ J ]. Circulation, 2001, 103 : 1955 - 1960.
4Ridker PM. High sensitivity C - reactive protein potential ad- junct for global assessment in the primary prevention of cardio- vascular disease[ J]. Circulation,2001,103 : 1813 - 1818.
5Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteinases- 2 and -9 are elevated in patients with acute coronary syndromes[ J]. J Am Coil Cardiol, 1998,32: 368 - 372.
